Summary
Synthetic oxytocin overuse in maternity care is a growing concern. This article reviews potential risks and anecdotal evidence from midwives and women regarding its use.
Area of Science:
- Obstetrics and Gynecology
- Pharmacology
- Sociology of Health
Background:
- The use of synthetic oxytocin in labor and delivery is common practice.
- Concerns are emerging regarding its potential overuse in maternity settings.
- This contrasts with the typical understanding of "drug abuse" in non-medical contexts.
Purpose of the Study:
- To overview the issues surrounding synthetic oxytocin overuse in maternity care.
- To present risks identified by research, social scientists, and childbirth commentators.
- To include anecdotal discussions from midwives and the experiences of women.
Main Methods:
- Literature review of recent research on synthetic oxytocin risks.
- Synthesis of commentary from social scientists and childbirth experts.
- Inclusion of anecdotal evidence and women's experiences.
Main Results:
- Identified risks associated with synthetic oxytocin use in labor.
- Documented concerns from various stakeholders including healthcare professionals and patients.
- Highlighted the gap between clinical practice and patient/provider perspectives.
Conclusions:
- There is a need to critically evaluate the current use of synthetic oxytocin in maternity care.
- Further research and open discussion are warranted to address potential overuse.
- Prioritizing women's experiences is crucial in understanding the impact of synthetic oxytocin administration.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
1.5K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K
Neurotransmitters
4.0K
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
4.0K
Opioid Analgesics: Morphine and Other Natural Cogeners
1.5K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.5K
Effects of Chemicals: Overview
2.4K
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
2.4K
Opioid Receptors: Overview
6.7K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
6.7K
Intrauterine Drug Delivery Systems
129
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
129


